Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |